ESC 365 - SGLT2-inhibitors and iron status in heart failure

Premium Access

SGLT2-inhibitors and iron status in heart failure

Session: The cardiometabolic syndrome and extracardiac drug effects beneficial to the heart

Topic: Drugs, Drug Targets

Speaker: Doctor J. Nunez Villota (Valencia, ES)

Event: HFA Winter Research Meeting on Translational Heart Failure 2025

Seminar Presentation

Add to my library

About the speaker

Doctor Julio Nunez Villota

Instituto de Investigacion Sanitaria INCLIVA, Valencia (Spain)

12 presentations

1 follower

3 more presentations in this session

Off target effects of SGLT2-inhibitors

Speaker: Assistant Professor C. Zuurbier (Amsterdam, NL)

Metabolic alterations and post-translational modifications in the failing heart

Speaker: Professor L. Bertrand (Brussels, BE)

The cardioprotective effects of semaglutide exceed those of dietary weight loss in mice with HFpEF

Speaker: Professor R. De Boer (Rotterdam, NL)

Access the full session

The cardiometabolic syndrome and extracardiac drug effects beneficial to the heart

Speakers: Doctor J. Nunez Villota, Assistant Professor C. Zuurbier, Professor L. Bertrand, Professor R. De Boer

About the event

HFA Winter Research Meeting on Translational Heart Failure 2025

20 January - 22 January 2025

Seminar

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources